Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT00248092 Completed - Clinical trials for Substance-Related Disorders

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Start date: January 2006
Phase: Phase 1/Phase 2
Study type: Interventional

This research is being done to evaluate if NRP104 is a safe drug. The other purpose is to learn if NRP104 produces a high and any other effects like amphetamine and other stimulant drugs that are abused. This information will give some indication if NRP104 can be abused. NRP104 is an investigational drug. This means that it has not been approved by the U.S. Food and Drug Administration (FDA). Healthy people, between the ages of 18 and 55 with histories of substance abuse that include stimulant drugs, may join. Amphetamines are drugs that are used most often to treat attention deficit hyperactivity disorder (ADHD) in children, to treat narcolepsy (excessive sleepiness) and for weight loss.

NCT ID: NCT00247572 Completed - Clinical trials for Substance-Related Disorders

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This research is being done to evaluate if NRP 104 is a safe drug. The other purpose is to learn if NRP104, when injected into a vein, produces a high and any other effects like amphetamine and other stimulant drugs that are abused. This information will give some indication if NRP104 can be abused. Healthy people, between the ages of 18 and 55 with histories of substance abuse that include stimulant drugs, may join. Amphetamines are drugs that are used most often to treat attention deficit hyperactivity disorder (ADHD) in children, to treat narcolepsy (excessive sleepiness) and for weight loss.

NCT ID: NCT00247234 Completed - Clinical trials for Personality Disorder, Borderline

Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

Start date: September 2004
Phase: N/A
Study type: Interventional

This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.

NCT ID: NCT00246441 Completed - Clinical trials for Alcohol Use Disorder

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Start date: March 2002
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether an SSRI, paroxetine, improves social anxiety symptoms and alcohol use in individuals who drink to cope with social anxiety disorder.

NCT ID: NCT00246259 Completed - Schizophrenia Clinical Trials

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Start date: October 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness, safety and tolerability of risperidone long-acting injection (LAI) versus oral antipsychotics in participants with recent onset psychosis (abnormal thinking and/or hallucinations).

NCT ID: NCT00246051 Completed - Clinical trials for Sleep Apnea, Obstructive

Comprehensive Police Fatigue Management Program

Start date: November 2005
Phase: N/A
Study type: Interventional

Police officers work some of the most demanding schedules known, which increases their risk of sleep deprivation and sleep disorders. The need to work frequent overnight shifts and long work weeks leads to acute and chronic partial sleep deprivation as well as misalignment of circadian phase. The public expects officers to perform flawlessly, but sleep deprivation and unrecognized sleep disorders significantly degrade cognition, alertness, reaction time and performance. In addition, both acute and chronic sleep deprivation adversely affect personal health, increasing the risk of gastrointestinal and heart disease, impairing glucose metabolism, and substantially increasing the risk of injury due to motor vehicle crashes. We propose to conduct a randomized, prospective study of the effect on the safety, health, and performance of a police department of a Comprehensive Police Fatigue Management Program (CPFMP) consisting of the following interventions: 1. identification and treatment of police with sleep disorders; 2. caffeine re-education; and 3. initiation of a sleep, health and safety educational program. These interventions were chosen because we believe them most likely to lead to measurable improvements on work hours, health, safety, and job performance, and because they are cost effective. The success of the CPFMP will be assessed through an experimental comparison with a standard treatment group that will receive sleep education in the absence of any accompanying interventions. The overall goal of our team will be sleep health detection and treatment program that can be disseminated to practitioners, policymakers and researchers nationwide to reduce police officer fatigue and stress; enhance the ability of officers to cope with shift schedules; improve the health, safety and performance of law enforcement officers; and thereby improve public safety.

NCT ID: NCT00245635 Completed - Clinical trials for Body Dysmorphic Disorder

Fluoxetine in Pediatric Body Dysmorphic Disorder

FDA BDD
Start date: November 2004
Phase: Phase 4
Study type: Interventional

This trial will study the effectiveness of the medication fluoxetine for children and adolescents ages 16 and younger with BDD who qualify.

NCT ID: NCT00244335 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress Disorder

Start date: October 2000
Phase: Phase 1/Phase 2
Study type: Observational

Post-traumatic stress disorder (PTSD) is a serious illness, in which individuals often experience anxiety and stress. Some individuals with PTSD use drugs to alleviate emotional distress. This study will examine the role that negative emotional states play in sedative drug use among individuals with PTSD.

NCT ID: NCT00241176 Completed - Tic Disorders Clinical Trials

Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if Abilify will reduce tics (repetitive, uncontrollable movements or vocalizations) in children and adolescents ages 7-18 with Tourette's Disorder (TD) or a chronic motor tic disorder (either repetitive, uncontrollable movements or vocalizations).

NCT ID: NCT00240721 Completed - Mood Disorders Clinical Trials

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Start date: October 2000
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the treatment of acute manic or mixed episodes in patients with Bipolar I Disorder.